[ON LEPTOSPIRAL UVEITIS].
D000287:Administration, Topical; D000900:Anti-Bacterial Agents; D001285:Atropine; D003168:Complement Fixation Tests; D004813:Epidemiology; D005387:Finland; D005853:Geriatrics; D006384:Hemagglutination; D006801:Humans; D007841:Latex Fixation Tests; D041383:Leptospira interrogans serovar icterohaemorrhagiae; D007922:Leptospirosis; D010656:Phenylephrine; D011239:Prednisolone / Q000008:administration & dosage* / Q000627:therapeutic use*; D014605:Uveitis
D000900:Anti-Bacterial Agents; D010656:Phenylephrine; D001285:Atropine; D011239:Prednisolone
ANTIBIOTICS; ATROPINE; COMPLEMENT FIXATION TESTS; EPIDEMIOLOGY; FINLAND; GERIATRICS; HEMAGGLUTINATION; LATEX FIXATION TESTS; LEPTOSPIRA CANICOLA; LEPTOSPIRA ICTEROHAEMORRHAGIAE; LEPTOSPIROSIS; PHENYLEPHRINE; PREDNISOLONE, THERAPEUTIC; PREDNISOLONE, TOPICAL; UVEITIS
UBER LEPTOSPIRENUVEITIS.